Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$209.01 - $232.56 $4.61 Million - $5.13 Million
-22,038 Reduced 40.4%
32,515 $7.1 Million
Q4 2023

Feb 01, 2024

BUY
$197.69 - $227.29 $2.16 Million - $2.48 Million
10,933 Added 25.06%
54,553 $12.4 Million
Q3 2023

Oct 19, 2023

BUY
$201.05 - $221.7 $6.02 Million - $6.64 Million
29,928 Added 218.58%
43,620 $8.77 Million
Q2 2023

Aug 02, 2023

BUY
$211.93 - $241.33 $14,411 - $16,410
68 Added 0.5%
13,692 $3.3 Million
Q1 2023

Apr 28, 2023

BUY
$213.32 - $257.83 $385,042 - $465,383
1,805 Added 15.27%
13,624 $3.13 Million
Q4 2022

Feb 07, 2023

SELL
$203.72 - $248.97 $3.28 Million - $4.01 Million
-16,112 Reduced 57.69%
11,819 $2.78 Million
Q3 2022

Oct 27, 2022

BUY
$204.81 - $262.19 $760,254 - $973,249
3,712 Added 15.33%
27,931 $5.72 Million
Q2 2022

Aug 03, 2022

BUY
$213.86 - $277.87 $2.01 Million - $2.62 Million
9,422 Added 63.68%
24,219 $5.68 Million
Q1 2022

May 11, 2022

BUY
$259.82 - $298.18 $1.25 Million - $1.43 Million
4,806 Added 48.1%
14,797 $3.9 Million
Q4 2021

Feb 08, 2022

SELL
$271.6 - $314.21 $660,531 - $764,158
-2,432 Reduced 19.58%
9,991 $3.14 Million
Q2 2021

Aug 03, 2021

SELL
$251.87 - $278.14 $2.73 Million - $3.01 Million
-10,820 Reduced 46.55%
12,423 $3.43 Million
Q1 2021

Apr 29, 2021

BUY
$204.88 - $255.03 $102,440 - $127,515
500 Added 2.2%
23,243 $5.93 Million
Q4 2020

Feb 11, 2021

BUY
$186.91 - $214.42 $112,146 - $128,651
600 Added 2.71%
22,743 $4.63 Million
Q3 2020

Nov 13, 2020

BUY
$167.03 - $201.3 $133,624 - $161,040
800 Added 3.75%
22,143 $4.17 Million
Q2 2020

Aug 13, 2020

BUY
$113.31 - $182.44 $2.42 Million - $3.89 Million
21,343 New
21,343 $3.55 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.